Salomon & Ludwin, LLC Astrazeneca PLC Transaction History
Salomon & Ludwin, LLC
- $933 Million
- Q1 2025
A detailed history of Salomon & Ludwin, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Salomon & Ludwin, LLC holds 32 shares of AZN stock, worth $2,306. This represents 0.0% of its overall portfolio holdings.
Number of Shares
32
Previous 74
56.76%
Holding current value
$2,306
Previous $4,000
50.0%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding AZN
# of Institutions
1,393Shares Held
476MCall Options Held
6MPut Options Held
4.4M-
Price T Rowe Associates Inc Baltimore, MD60.4MShares$4.35 Billion0.46% of portfolio
-
Primecap Management CO Pasadena, CA40.7MShares$2.93 Billion2.53% of portfolio
-
Capital International Investors Los Angeles, CA37.5MShares$2.7 Billion0.48% of portfolio
-
Bank Of America Corp Charlotte, NC24MShares$1.73 Billion0.13% of portfolio
-
Franklin Resources Inc San Mateo, CA19.5MShares$1.4 Billion0.37% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $223B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...